Shen CH - Search Results

1

NECTIN4: A Novel Therapeutic Target for Melanoma.

Tanaka Y, Murata M, Shen CH, Furue M, Ito T. Tanaka Y, et al. Among authors: shen ch. Int J Mol Sci. 2021 Jan 19;22(2):976. doi: 10.3390/ijms22020976. Int J Mol Sci. 2021. PMID: 33478111 Free PMC article.

2

The Potential of Targeting P53 and HSP90 Overcoming Acquired MAPKi-Resistant Melanoma.

Hsieh CC, Shen CH. Hsieh CC, et al. Among authors: shen ch. Curr Treat Options Oncol. 2019 Feb 18;20(3):22. doi: 10.1007/s11864-019-0622-9. Curr Treat Options Oncol. 2019. PMID: 30778775 Review.

3

Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival.

Ito T, Kaku-Ito Y, Murata M, Furue K, Shen CH, Oda Y, Furue M. Ito T, et al. Among authors: shen ch. J Clin Med. 2020 Mar 4;9(3):690. doi: 10.3390/jcm9030690. J Clin Med. 2020. PMID: 32143442 Free PMC article.

4

TRPM1 promotes tumor progression in acral melanoma by activating the Ca²⁺/CaMKIIδ/AKT pathway.

Hsieh CC, Su YC, Jiang KY, Ito T, Li TW, Kaku-Ito Y, Cheng ST, Chen LT, Hwang DY, Shen CH. Hsieh CC, et al. Among authors: shen ch. J Adv Res. 2023 Jan;43:45-57. doi: 10.1016/j.jare.2022.03.005. Epub 2022 Mar 12. J Adv Res. 2023. PMID: 36585114 Free PMC article.

5

RNF43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer Cells.

Hsu SH, Tsai YL, Wang YT, Shen CH, Hung YH, Chen LT, Hung WC. Hsu SH, et al. Among authors: shen ch. Adv Sci (Weinh). 2024 Mar;11(12):e2304820. doi: 10.1002/advs.202304820. Epub 2024 Jan 15. Adv Sci (Weinh). 2024. PMID: 38225722 Free PMC article.

6

AUY922 induces retinal toxicity through attenuating TRPM1.

Shen CH, Hsieh CC, Jiang KY, Lin CY, Chiang NJ, Li TW, Yen CT, Chen WJ, Hwang DY, Chen LT. Shen CH, et al. J Biomed Sci. 2021 Jul 23;28(1):55. doi: 10.1186/s12929-021-00751-5. J Biomed Sci. 2021. PMID: 34301262 Free PMC article.

7

CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer.

Hsieh CC, Hsu SH, Lin CY, Liaw HJ, Li TW, Jiang KY, Chiang NJ, Chen SH, Lin BW, Chen PC, Chan RH, Lin PC, Yeh YM, Shen CH. Hsieh CC, et al. Among authors: shen ch. Br J Cancer. 2022 Nov;127(9):1615-1628. doi: 10.1038/s41416-022-01946-9. Epub 2022 Aug 23. Br J Cancer. 2022. PMID: 35999268 Free PMC article.

8

Exon Junction Complex Mediates the Cap-Independent Translation of Circular RNA.

Lin HH, Chang CY, Huang YR, Shen CH, Wu YC, Chang KL, Lee YC, Lin YC, Ting WC, Chien HJ, Zheng YF, Lai CC, Hsiao KY. Lin HH, et al. Among authors: shen ch. Mol Cancer Res. 2023 Nov 1;21(11):1220-1233. doi: 10.1158/1541-7786.MCR-22-0877. Mol Cancer Res. 2023. PMID: 37527157

9

Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients.

Chen YL, Lee KT, Wang CY, Shen CH, Chen SC, Chung WP, Hsu YT, Kuo YL, Chen PS, Cheung CHA, Chang CP, Shen MR, Hsu HP. Chen YL, et al. Among authors: shen ch, shen mr. Am J Cancer Res. 2022 May 15;12(5):2084-2101. eCollection 2022. Am J Cancer Res. 2022. PMID: 35693094 Free PMC article.

10

APLF facilitates interstrand DNA crosslink repair and replication fork protection to confer cisplatin resistance.

Wu CK, Shiu JL, Wu CL, Hung CF, Ho YC, Chen YT, Tung SY, Yeh CF, Shen CH, Liaw H, Su WP. Wu CK, et al. Among authors: shen ch. Nucleic Acids Res. 2024 Mar 23:gkae211. doi: 10.1093/nar/gkae211. Online ahead of print. Nucleic Acids Res. 2024. PMID: 38520407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

596 results

Search Page